Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta EM Horwitz, DJ Prockop, LA Fitzpatrick, WWK Koo, PL Gordon, M Neel, ... Nature medicine 5 (3), 309-313, 1999 | 2310 | 1999 |
A distinct “side population” of cells with high drug efflux capacity in human tumor cells C Hirschmann-Jax, AE Foster, GG Wulf, JG Nuchtern, TW Jax, U Gobel, ... Proceedings of the National Academy of Sciences 101 (39), 14228-14233, 2004 | 1550 | 2004 |
Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation CM Rooney, CYC Ng, S Loftin, CA Smith, C Li, RA Krance, MK Brenner, ... The Lancet 345 (8941), 9-13, 1995 | 1237 | 1995 |
Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus–induced lymphoma in allogeneic transplant recipients CM Rooney, CA Smith, CYC Ng, SK Loftin, JW Sixbey, Y Gan, ... Blood, The Journal of the American Society of Hematology 92 (5), 1549-1555, 1998 | 1232 | 1998 |
Inducible apoptosis as a safety switch for adoptive cell therapy A Di Stasi, SK Tey, G Dotti, Y Fujita, A Kennedy-Nasser, C Martinez, ... N Engl J Med 365, 1673-1683, 2011 | 1166 | 2011 |
Gene-marking to trace origin of relapse after autologous bone-marrow transplantation MK Brenner, DR Rill, RA Krance, JN Ihle, RC Moen, J Mirro, WF Anderson The Lancet 341 (8837), 85-86, 1993 | 1121 | 1993 |
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma MA Pule, B Savoldo, GD Myers, C Rossig, HV Russell, G Dotti, MH Huls, ... Nature medicine 14 (11), 1264-1270, 2008 | 1102 | 2008 |
CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients B Savoldo, CA Ramos, E Liu, MP Mims, MJ Keating, G Carrum, ... The Journal of clinical investigation 121 (5), 1822-1826, 2011 | 927 | 2011 |
Long–term restoration of immunity against Epstein–Barr virus infection by adoptive transfer of gene–modified virus–specific T lymphocytes HE Heslop, CYC Ng, C Li, CA Smith, SK Loftin, RA Krance, MK Brenner, ... Nature medicine 2 (5), 551-555, 1996 | 927 | 1996 |
Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma CU Louis, B Savoldo, G Dotti, M Pule, E Yvon, GD Myers, C Rossig, ... Blood, The Journal of the American Society of Hematology 118 (23), 6050-6056, 2011 | 917 | 2011 |
Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta EM Horwitz, DJ Prockop, PL Gordon, WWK Koo, LA Fitzpatrick, MD Neel, ... Blood, The Journal of the American Society of Hematology 97 (5), 1227-1231, 2001 | 732 | 2001 |
Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients HE Heslop, KS Slobod, MA Pule, GA Hale, A Rousseau, CA Smith, ... Blood, The Journal of the American Society of Hematology 115 (5), 925-935, 2010 | 721 | 2010 |
Human epidermal growth factor receptor 2 (HER2)–specific chimeric antigen receptor–modified T cells for the immunotherapy of HER2-positive sarcoma N Ahmed, VS Brawley, M Hegde, C Robertson, A Ghazi, C Gerken, E Liu, ... Journal of clinical oncology 33 (15), 1688, 2015 | 627 | 2015 |
An inducible caspase 9 safety switch for T-cell therapy KC Straathof, MA Pule, P Yotnda, G Dotti, EF Vanin, MK Brenner, ... Blood 105 (11), 4247-4254, 2005 | 564 | 2005 |
Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals AM Leen, GD Myers, U Sili, MH Huls, H Weiss, KS Leung, G Carrum, ... Nature medicine 12 (10), 1160-1166, 2006 | 548 | 2006 |
Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells DR Rill, VM Santana, WM Roberts, T Nilson, LC Bowman, RA Krance, ... | 480 | 1994 |
Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus LV Gubareva, MN Matrosovich, MK Brenner, RC Bethell, RG Webster The Journal of infectious diseases 178 (5), 1257-1262, 1998 | 477 | 1998 |
Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients MK Brenner, VM Santana, DR Rill, MS Holladay, HE Heslop, M Buschle, ... The Lancet 342 (8880), 1134-1137, 1993 | 462 | 1993 |
Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus+ Hodgkin's Disease CM Bollard, L Aguilar, KC Straathof, B Gahn, MH Huls, A Rousseau, ... The Journal of experimental medicine 200 (12), 1623-1633, 2004 | 447 | 2004 |
A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells MA Pulè, KC Straathof, G Dotti, HE Heslop, CM Rooney, MK Brenner Molecular Therapy 12 (5), 933-941, 2005 | 444 | 2005 |